Chaudhari; Sachin Sundarlal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chaudhari; Sachin Sundarlal.The latest application filed is for "substituted bicyclic heterocyclic compounds as nadph oxidase inhibitors".

Company Profile

1.14.13

Chaudhari; Sachin Sundarlal - Navi Mumbai Maharshtra
Chaudhari; Sachin Sundarlal - Maharashtra IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Bicyclic Heterocyclic Compounds As Nadph Oxidase Inhibitors App 20200247800 - Kind Code	2020-08-06
Bicyclic heteroaryl indole analogues useful as ROR gamma modulators Grant 9,682,977 - Das , et al. June 20, 2	2017-06-20
Bicyclic Heteroaryl Indole Analogues Useful As Ror Gamma Modulators App 20160326163 - DAS; Sanjib ; et al.	2016-11-10
Treatment of respiratory disorders using TRPA1 antagonists Grant 9,186,360 - Khairatkar-Joshi , et al. November 17, 2	2015-11-17
2-amino-4-arylthiazole compounds as TRPA1 antagonists Grant 9,073,955 - Kumar , et al. July 7, 2	2015-07-07
Fused pyrimidine-dione derivatives as TRPA1 modulators Grant 9,000,159 - Chaudhari , et al. April 7, 2	2015-04-07
2-amino-4-arylthiazole compounds as TRPA1 antagonists Grant 8,889,862 - Kumar , et al. November 18, 2	2014-11-18
Fused Pyrimidine-dione Derivatives As Trpa1 Modulators App 20140128603 - Chaudhari; Sachin Sundarlal ; et al.	2014-05-08
2-amino-4-arylthiazole Compounds As Trpa1 Antagonists App 20140051667 - Kumar; Sukeerthi ; et al.	2014-02-20
2-amino-4-arylthiazole Compounds As Trpa1 Antagonists App 20140045865 - Kumar; Sukeerthi ; et al.	2014-02-13
Fused pyrimidine-dione derivatives as TRPA1 modulators Grant 8,623,880 - Chaudhari , et al. January 7, 2	2014-01-07
2-amino-4-arylthiazole compounds as TRPA1 antagonists Grant 8,592,398 - Kumar , et al. November 26, 2	2013-11-26
Fused pyrimidineone compounds as TRPV3 modulators Grant 8,518,955 - Lingam , et al. August 27, 2	2013-08-27
Treatment Of Respiratory Disorders Using Trpa1 Antagonists App 20120316136 - KHAIRATKAR-JOSHI; Neelima ; et al.	2012-12-13
Fused imidazole carboxamides as TRPV3 modulators Grant 8,318,928 - Chaudhari , et al. November 27, 2	2012-11-27
Furopyrimidinedione Derivatives As Trpai Modulators App 20120178766 - Chaudhari; Sachin Sundarlal ; et al.	2012-07-12
2-amino-4-arylthiazole Compounds As Trpai Antagonists App 20120157411 - Kumar; Sukeerthi ; et al.	2012-06-21
Fused Pyrimidineone Compounds As Trpv3 Modulators App 20120108813 - LINGAM; Prasada Rao V.S. ; et al.	2012-05-03
Fused pyrimidineone compounds as TRPV3 modulators Grant 8,119,647 - Lingam , et al. February 21, 2	2012-02-21
Fused Pyrimidine-dione Derivatives As Trpai Modulators App 20120041004 - Chaudhari; Sachin Sundarlal ; et al.	2012-02-16
Chromenone Derivatives As Trpv3 Antagonists App 20110237659 - Chaudhari; Sachin Sundarlal ; et al.	2011-09-29
Fused Imidazole Carboxamides As Trpv3 Modulators App 20100152192 - Chaudhari; Sachin Sundarlal ; et al.	2010-06-17
Fused Pyrimidineone Compounds As Trpv3 Modulators App 20090286811 - Lingham; Prasada Rao V.S. ; et al.	2009-11-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.